Cognitive-behavioral Treatment for Rheumatoid Arthritis
2 other identifiers
interventional
150
1 country
1
Brief Summary
To evaluate the effectiveness of Cognitive-behavioral treatment for people with rheumatoid arthritis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable rheumatoid-arthritis
Started Oct 2014
Longer than P75 for not_applicable rheumatoid-arthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 2, 2014
CompletedFirst Posted
Study publicly available on registry
October 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedApril 4, 2017
March 1, 2017
3.6 years
October 2, 2014
March 31, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Changes from baseline in disease activity score in 28 joints(DAS28) at 48 weeks
at 0 week, 12 weeks, 24 weeks, 48 weeks
Study Arms (2)
CBT
EXPERIMENTALCognitive-behavioral treatment
WLT
SHAM COMPARATORWaiting in list
Interventions
Eligibility Criteria
You may qualify if:
- diagnosed by rheumatology consultants with RA
You may not qualify if:
- severe psychological difficulties
- currently receiving mental health care
- any medical condition that might prevent them from safely exercising (e.g. history of more severe heart, lung or cerebrovascular disease)
- previously attended an education programme
- had a Modified Health Assessment Questionnaire score \>2 (score range 0-3), that is severe functional problems
- history of organic brain syndrome
- presence of a psychotic disorder
- presence of other uncontrolled medical disorders
- presence of a major communication disorder, illiteracy
- presence of less than an 8th grade education (due to inability to complete questionnaires)
- presence of a therapeutic dosage of an antidepressant medication, or presence of another autoimmune disease/disabling condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General Hospital of Chengdu Military Area Command PLA
Chengdu, Sichuan, 610083, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
October 2, 2014
First Posted
October 6, 2014
Study Start
October 1, 2014
Primary Completion
May 1, 2018
Study Completion
July 1, 2020
Last Updated
April 4, 2017
Record last verified: 2017-03